Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,227 public trials 1,016 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)

NCT02437136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • University of Maryland, Marlene and Stewart Greenbaum Cancer Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment

NCT04256707

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Hadassah Ein Karem University Hospital Jerusalem, Israel
  • University Hospital Assuta Ashdod Ashdod, Israel
  • Soroka University Medical Center Beersheba, Israel
  • Oncology Department Hillel Yaffe Medical Center Hadera, Israel
View Trial Details
Completed

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

NCT02783300

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

NCT05619744

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations
  • Georgetown Uni Medical Center Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 17 locations
View Trial Details
Completed

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR

NCT00446225

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier Universitaire D'Angers Angers, France
  • Hôpital Auguste Morvan Brest, France
  • Centre François Baclesse Caen, France
  • Centre Hospitalier René Dubos Cergy-Pontoise, France
View all 76 locations
View Trial Details

Related conditions